22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...

22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020 Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...

22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...